ArticleNeuro-oncology2020
LY6K promotes glioblastoma tumorigenicity via CAV-1-mediated ERK1/2 signaling enhancement.
Namratha G Sastry et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it
ArticleNeuro-oncology2020
Namratha G Sastry et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.